| Name | Title | Contact Details |
|---|
ALung Technologies has developed the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis,a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patients lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).
Hospicelink has created a nationally recognized , award winning software solution, specifically focused on the unique relationship between Hospice Companies and DME Providers. Although the needs of each Company can be vastly different, we understand the pressures in today`s marketplace and the difficulties these create for the industry. Hospicelink has addressed the challenges of providing optimal care while maintaining compliance and improving operational efficiencies, enabling your staff to balance multiple responsibilities. Hospicelink has a proven track record of helping clients solve these problems through our comprehensive set of innovative solutions. Our state-of-the-art application assists Hospice Companies and DME Providers with the ordering, billing, reporting and contract management processes. Hospicelink`s Executive Dashboard provides access to real-time actionable data, allowing a proactive response and improvement of identified inefficiencies.
NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
On-site health services for employers nation wide. Work Health Solutions keep workplaces safe and OSHA-compliant by offering onsite medical surveillance testing and occupational medical exams. In addition we also offer customized programs to meet your on-site medical needs. Wellness clinics, primary care, preventative program and full occupational health services.